TY - JOUR A2 - Silvestris，尼古拉AU - 刘，Sulai AU - 刘新余AU - 李，李学鹏AU - 李，欧盟 - 毅，为民AU - 汗，朱奈德AU - 杨，平洲AU - 郭沫若超AU -彭庄AU - 江博PY - 2020 DA - 2020年2月25日TI - 1506275 VL - - 2020 AB腹腔镜根治性切除的类型III和IV肝门部胆管癌治疗SP应用 - 背景。此研究的目的是调查腹腔镜根治性切除的可行性和安全性用于治疗III型和IV肝门胆管癌（III / IV肺门C）。 方法。6例III / IV肺门下，在我们医院的患者。所有患者接受总腹腔镜手术，包括基本的手术（腹腔镜胆囊，肝门部胆管，和导管切除和肝十二指肠韧带淋巴结清扫胆总管）与肝左和尾状叶切除/门户切除组合。观察肿瘤大小，手术时间，术中出血，和术后并发症。患者随访出院后的记录。 结果。手术6例成功完成。We found that the tumor size of 6 patients ranged from 1.5 to 3.6 cm, with 4 lymph nodes. The operation time was 540-660 minutes, and the blood loss was 300-500 ml. One patient developed bile leakage after surgery, healed within 2 weeks after drainage. The postoperative hospital stay was 16 (13-24) days. There were 4 cases of negative bile duct margin tumor, 1 case was positive, and 1 case was not reported. All 6 patients were discharged smoothly without perioperative death. Regular examinations were conducted every 3 months after discharge, and the median duration was 7 months. Only 1 patient had a marginal dysplasia, and 5 patients had no obvious signs of recurrence. 结论。腹腔镜根治术III / IV肺门的C应用是安全可行的，并且具有足够的术前评估，适当情况下的选择，和精确的操作策略良好的短期疗效。SN - 1687-6121 UR - https://doi.org/10.1155/2020/1506275 DO - 10.1155 /一百五十万六千二百七十五分之二千零二十○JF - 消化内科的研究与实践PB - Hindawi出版KW - ER -